Gastric carcinoma
MONDO:0004950A carcinoma that arises from epithelial cells of the stomach.
Also known as: cancer of stomach, cancer of the stomach, gastric (stomach) cancer, gastric cancer, gastric cancer, NOS, stomach cancer, carcinoma of stomach, carcinoma of the stomach
3389 clinical trials for this condition and its sub-types, 92 tagged with Gastric carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Gastric carcinoma
-
Gastric adenocarcinoma 449 trials · 481 incl. sub-types
9 sub-types
- Microinvasive gastric cancer 28 trials
- Diffuse gastric adenocarcinoma 1 trial · 5 incl. sub-types Sub-types →
- Gastric cardia adenocarcinoma 4 trials
- Signet ring cell gastric adenocarcinoma 2 trials
- CTNNA1-related diffuse gastric and lobular breast cancer syndrome 0 trials
- Gastric intestinal type adenocarcinoma 0 trials
- Gastric papillary adenocarcinoma 0 trials
- Gastric tubular adenocarcinoma 0 trials
- Mucinous gastric adenocarcinoma 0 trials
-
Gastric cardia carcinoma 3 trials · 7 incl. sub-types
2 sub-types
- Gastric cardia adenocarcinoma 4 trials
- Carcinoma in situ of gastric cardia 0 trials
-
Hereditary gastric cancer 1 trial · 6 incl. sub-types
-
Gastric squamous cell carcinoma 4 trials
1 sub-type
- Gastric adenosquamous carcinoma 0 trials
-
Stomach carcinoma in situ 4 trials
3 sub-types
- Carcinoma in situ of fundus of stomach 0 trials
- Carcinoma in situ of gastric body 0 trials
- Carcinoma in situ of gastric cardia 0 trials
-
Gastric body carcinoma 1 trial
1 sub-type
- Carcinoma in situ of gastric body 0 trials
-
Gastric fundus carcinoma 0 trials
1 sub-type
-
Gastric pylorus carcinoma 0 trials
Most studied deeper sub-types
-
Can a pill target cancers with a specific gene flaw?
Disease control Not yet recruitingThis phase II trial tests an experimental drug called TR115 in people with advanced solid tumors that have a mutation in the ARID1A gene. The study includes patients with platinum-resistant ovarian clear cell carcinoma, endometrial cancer that failed immunotherapy, and other tumo…
Phase 2 • Sponsor: Tarapeutics Science Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New drug cocktail aims to fight Hard-to-Treat stomach cancers
Disease control Not yet recruitingThis early-phase trial tests whether adding the experimental drug futibatinib to standard chemotherapy (paclitaxel) and an antibody (ramucirumab) is safe for people with advanced stomach, gastroesophageal junction, or esophageal cancer that cannot be removed by surgery. The study…
Phase 1 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Engineered immune cells take on stomach cancer in new trial
Disease control Not yet recruitingThis early-stage trial tests a new type of cell therapy called CAR-T cells that are designed to target two proteins (CD73 and AXL) found on stomach cancer cells. The study will enroll 42 people with stage IV stomach cancer that has not responded to standard treatments. The main g…
Phase 1/2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug cocktail aims to shrink stomach tumors before surgery
Disease control Not yet recruitingThis Phase 3 trial tests whether adding an immunotherapy drug (adebrelimab) and a targeted therapy (apatinib) to standard chemotherapy (SOX) can improve outcomes for people with locally advanced stomach cancer that cannot be removed right away. The study will enroll 118 participa…
Phase 3 • Sponsor: Fujian Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Remote workouts aim to restore strength in cancer survivors
Symptom relief Not yet recruitingThis study tests whether a personalized, supervised exercise program done at home can improve physical function in people who have finished treatment for gastroesophageal cancer. About 20 survivors will receive tailored aerobic and resistance exercises via video calls. The goal i…
Sponsor: Jonsson Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New study tracks physical decline during cancer treatment
Knowledge-focused Not yet recruitingThis study will follow 72 adults with early-stage gastroesophageal cancer to see how their physical function changes during chemotherapy. Participants will have their physical abilities measured at several points over six months. The goal is to understand which patients are at ri…
Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC